Kaisa Huhtinen
Turun yliopisto
H-index: 25
Europe-Finland
Top articles of Kaisa Huhtinen
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Abstract A003: Characterizing DNA methylation patterns driving chemotherapy resistance in ovarian high-grade serous carcinoma | Cancer Research | Alexandra Lahtinen Giovanni Marchi Kari Lavikka Giulia Micoli Susanna Holmström | 2024/3/4 |
Establishment and analysis of patient-derived high-grade serous ovarian cancer organoids for disease modeling and drug testing | Cancer Research | Tuula Kallunki Anna R Lauridsen Aikaterini Skorda Alexandra Lahtinen Marie L Bay | 2024/3/22 |
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma | BMC cancer | Sanaz Jamalzadeh Jun Dai Kari Lavikka Yilin Li Jing Jiang | 2024/2/5 |
Application of high-grade serous ovarian cancer organoids in functional precision medicine | Cancer Research | Wojciech Senkowski Laura Gall-Mas Matias M Falco Yilin Li Kari Lavikka | 2024/3/22 |
Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level | Scientific Reports | Anna Perkiö Barun Pradhan Fatih Genc Anna Pirttikoski Sanna Pikkusaari | 2024/2/21 |
Abstract B027: Screening of drug candidates to repurpose for high-grade serous ovarian cancer treatment | Cancer Research | Marie L Bay Aikaterini Skorda Benita S Rasmussen Jaume R Arias Anna R Lauridsen | 2024/3/4 |
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma | Gynecologic Oncology | Heidi Koskela Yilin Li Titta Joutsiniemi Taru Muranen Veli-Matti Isoviita | 2024/1/1 |
Abstract A027: Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma | Cancer Research | Sampsa Hautaniemi Sanaz Jamalzadeh Jun Dai Kari Lavikka Yilin Li | 2024/3/4 |
Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence | Translational oncology | Giovanni Marchi Anna Rajavuori Mai TN Nguyen Kaisa Huhtinen Sinikka Oksa | 2024/1/1 |
Abstract B102: Mutational and copy number-based ctDNA profiles mirror high-grade serous cancer tumors and enable detection of genetic changes appearing at recurrence | Cancer Research | Giovanni Marchi Mai TN Nguyen Anna Rajavuori Taru Muranen Kaisa Huhtinen | 2024/3/4 |
PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structures | Neoplasia | Heidi Rausio Alejandra Cervera Vanina D Heuser Gun West Jaana Oikkonen | 2024/5/1 |
Circulating tumor DNA-based copy-number profiles enable monitoring treatment effects during therapy in high-grade serous carcinoma | Biomedicine & Pharmacotherapy | Mai TN Nguyen Anna Rajavuori Kaisa Huhtinen Sakari Hietanen Johanna Hynninen | 2023/12/1 |
Functional homologous recombination assay on FFPE specimens of advanced high-grade serous ovarian cancer predicts clinical outcomes | Clinical Cancer Research | Sanna Pikkusaari Manuela Tumiati Anni Virtanen Jaana Oikkonen Yilin Li | 2023/8/15 |
Deciphering Cancer Genomes with GenomeSpy: A Grammar-Based Visualization Toolkit | bioRxiv | Kari Lavikka Jaana Oikkonen Yilin Li Taru Muranen Giulia Micoli | 2023 |
Multi-omics characterization of chemo-refractory HGSC patients | Cancer Research | Taru A Muranen Anna Rajavuori Daria Afenteva Kaisa Huhtinen Veli-Matti Isoviita | 2023/4/4 |
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids | Developmental Cell | Wojciech Senkowski Laura Gall-Mas Matías Marín Falco Yilin Li Kari Lavikka | 2023/6/19 |
776P Multi-omics analysis of chemo-refractory high-grade serous carcinoma patients: Insights from the DECIDER study | Annals of Oncology | D Afenteva TA Muranen A Rajavuori S Jamalzadeh K Zhang | 2023/10/1 |
Characterizing dynamic landscape of DNA methylation in ovarian high-grade serous carcinoma | Cancer Research | Alexandra Lahtinen Giovanni Marchi Daria Afenteva Susanna Holmström Kaisa Huhtinen | 2023/4/4 |
Aberrant glycosylation of α3 integrins as diagnostic markers in epithelial ovarian cancer | Clinica Chimica Acta | Shruti Jain Priyadharshini Parimelazhagan Santhi Rufus Vinod Shamima Afrin Ruma Kaisa Huhtinen | 2023/3/15 |
# 252 Evolutionary study identifies poor prognosis HGSC patients and reveals clinically relevant targets at diagnosis and relapse | Jaana Oikkonen Alexandra Lahtinen Kari Lavikka Anni Virtanen Yilin Li | 2023/9/1 |
